Mepinaest Purum (Mepivacaine Hydrochloride)

Mepivacaine Hydrochloride is used to provide local anesthesia in procedures involving the peripheral nervous system.

• Dental procedures: provides local anesthesia to facilitate pain‑free treatment of teeth and surrounding tissues.
• Minor surgical procedures: produces reversible loss of sensation to allow incision and suturing without discomfort.
• Minor orthopedic interventions: enables temporary numbness for small joint or soft‑tissue manipulations.

• Mepivacaine Hydrochloride blocks voltage‑gated sodium channels on neuronal membranes, preventing the rapid influx of sodium ions required for depolarisation. This reversible inhibition halts the propagation of nerve impulses, resulting in loss of sensation in the targeted area while preserving motor function at typical clinical concentrations.

Mepivacaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Injection site pain or burning sensation.
• Transient numbness or tingling beyond the intended area.
• Dizziness or light‑headedness.
• Metallic taste in the mouth.
• Mild tachycardia.
• Temporary hypotension.

Serious or Rare Side Effects

• Seizures or convulsive activity.
• Severe cardiac arrhythmias, including ventricular tachycardia.
• Anaphylactic or severe allergic reactions.
• Methemoglobinemia.
• Persistent neurological deficits.
• Cardiovascular collapse.

Prior to administration, clinicians should evaluate patient‑specific risk factors and follow standard safety protocols.

• Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.
• Cardiovascular status: monitor patients with existing heart disease or conduction abnormalities.
• Dosage limits: avoid exceeding the recommended maximum dose for the patient’s weight and age.
• Concurrent CNS depressants: use caution when combined with other agents that lower seizure threshold.
• Pregnancy and lactation: assess risk–benefit as safety data are limited.
• Store below 25°C: keep in the original container, protect from moisture and light.

Mepivacaine Hydrochloride can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma concentrations of mepivacaine.
• Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension.
• Beta‑blockers combined with epinephrine: may potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely)

• Other local anesthetics: additive toxicity risk.
• Central nervous system depressants (e.g., benzodiazepines, opioids): may enhance CNS depression.
• Diuretics: may alter plasma protein binding and affect drug levels.